4 completed, 1 active not recruiting. 5 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Active not recruiting 1 |
| Phase 1 | 4 | Completed 3, Active not recruiting 1 |
Follow pepinemab: new trials by email Literature Review of pepinemab trials Research Report on pepinemab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma Avelumab and Pepinemab - Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | Active not recruiting | Vaccinex Inc. | 48 | 2022-12-10 | 2025-05-21 |
| Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck pepinemab + pembrolizumab - Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) | Phase 1 / Phase 2 | Completed | Vaccinex Inc. | 49 | 2021-08-09 | 2025-01-08 |
| SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) Pepinemab, Placebo - Alzheimer Disease | Phase 1 / Phase 2 | Completed | Vaccinex Inc. | 50 | 2021-07-22 | 2024-08-22 |
| Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors Laboratory Biomarker Analysis, Pepinemab, Pharmacological Study - Recurrent Malignant Solid Neoplasm, Recurrent Osteosarcoma | Phase 1 / Phase 2 | Completed | Children's Oncology Group | 26 | 2018-01-31 | 2024-07-15 |
| A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi VX15/2503, Placebo - Huntington's Disease | Phase 2 | Completed | Vaccinex Inc. | 301 | 2015-07-01 | 2022-05-02 |
Alzheimer Disease (1) · Carcinoma (1) · Cognitive Dysfunction (1) · Huntington Disease (1) · Neoplasm Metastasis (1) · Osteosarcoma (1) · Prodromal Symptoms (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1)
Vaccinex Inc. (4) · Children's Oncology Group (1)
United States (5) · Canada (1)
Andrew Feigin, MD (1) · Daniel Mulkerin, MD (1) · Emily G Greengard (1) · Eric Siemers, MD (1)
PMID 30103342, PMID 31401903, PMID 35941373, PMID 36463457, PMID 38520670
UM1CA097452 (1)